Vanguard Group Inc Endra Life Sciences Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $319.0 $40,071 - $55.6 Million	-174,225 Reduced 14.88%	996,822 $305,000
Q2 2022 Aug 12, 2022	SELL	$0.19 - $0.45 $6,985 - $16,544	-36,765 Reduced 3.04%	1,171,047 $273,000
Q1 2022 May 13, 2022	SELL	$0.36 - $0.77 $181,425 - $388,048	-503,959 Reduced 29.44%	1,207,812 $471,000
Q4 2021 Feb 14, 2022	SELL	$0.69 - $1.73 $1,419 - $3,558	-2,057 Reduced 0.12%	1,711,771 $1.18 Million
Q3 2021 Nov 12, 2021	BUY	$1.38 - $2.15 $6,524 - $10,165	4,728 Added 0.28%	1,713,828 $2.97 Million
Q2 2021 Aug 13, 2021	BUY	$1.98 - $2.74 $3.38 Million - $4.68 Million	1,709,100 New	1,709,100 $3.73 Million

Ticker NDRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 63,174,500
Market Cap $311M
Description
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.